Literature DB >> 26314227

Cystic Brain Metastases Occurring in Anaplastic Lymphoma Kinase Gene Rearranged Non-Small-Cell Lung Cancer Patients Receiving Crizotinib.

Vignesh Narayanan1, M Justin Honce2, Sanjana Mehrotra3, D Ross Camidge4.   

Abstract

Entities:  

Keywords:  Anaplastic lymphoma kinase; Crizotinib; Cystic brain metastases; Non–small-cell lung cancer; Signet ring morphology

Mesh：

Substances：

Year:  2015        PMID： 26314227     DOI： 10.1016/j.cllc.2015.07.003

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  5 in total

1.  Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer.

Authors:  Yi-Bing Xu; Yiping Zhang; Zhengbo Song; Wenxian Wang; Lan Shao
Journal:  Cancer Manag Res       Date:  2021-08-10       Impact factor: 3.989

Review 2.  Tyrosine Kinase Inhibitor Therapy for Brain Metastases in Non-Small-Cell Lung Cancer: A Primer for Radiologists.

Authors:  C Dodson; T J Richards; D A Smith; N H Ramaiya
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-26       Impact factor: 3.825

Review 3.  Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

Authors:  Guilherme Nader Marta; Renata Rodrigues da Cunha Colombo Bonadio; Renata Eiras Martins; Henrique Bortot Zuppani; Gilberto de Castro
Journal:  Ecancermedicalscience       Date:  2018-03-14

Review 4.  Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer.

Authors:  Liting Guo; Haijun Zhang; Weiwei Shao; Baoan Chen
Journal:  Drug Des Devel Ther       Date:  2015-10-03       Impact factor: 4.162

5.  Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer.

Authors:  Bing Sun; Zhou Huang; Shikai Wu; Lijuan Ding; Ge Shen; Lei Cha; Junliang Wang; Santai Song
Journal:  Oncotarget       Date:  2016-11-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.